NOLVAMED 20 (Tamoxifen Citrate)

Active Substance: Tamoxifen Citrate (Nolvadex)
Manufacturer: Deus Medical
Pack: 1 Box of 2x 25 Tablets (20 mg/tab)
Form: Oral

What Is Tamoxifen Citrate (Nolvadex)?

Tamoxifen Citrate (NOLVAMED 20) is a crucial ancillary compound classified as a Selective Estrogen Receptor Modulator (SERM). It is not a steroid but is utilized for its powerful anti-estrogenic and restorative properties. Clinically, it is used as a preventative measure and treatment for certain types of breast cancer.

Tamoxifen works by selectively acting as an estrogen receptor antagonist (blocker) in tissues like the breast, while acting as an agonist (activator) in other tissues, such as the bone and liver.

Core Functions for Steroid Users

Nolvadex provides two fundamental and beneficial actions:

1. Gynecomastia Prevention (Receptor Blocker): Tamoxifen binds to estrogen receptors in breast tissue, effectively blocking circulating estrogen from causing breast gland growth. This is vital for preventing and treating developing gynecomastia (gyno).

2. Testosterone Restoration (PCT Catalyst): This is its most beneficial function in PCT. By blocking estrogen receptors in the pituitary gland, Nolvadex signals the body to release high amounts of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). Numerous studies show Tamoxifen dramatically increases these hormones, helping to restart and boost natural testosterone production.

Usage and Dosage Protocols

Tamoxifen is a foundational component of PCT, but it can also be used for on-cycle protection.

• Optimal PCT Dosage: The limited studies suggest 20 mg or 40 mg per day are suitable for raising testosterone levels. A 4 to 5 week use is generally sufficient to fully recover natural testosterone levels.

• On-Cycle Use: Some protocols recommend using Nolvadex throughout the steroid cycle, starting from the first day, to minimize the risk of gyno and help maintain hormonal balance.

• PCT Timing: Others advocate using Nolvadex only in PCT, starting when the active steroids have cleared the system (e.g., 3 weeks after the last long-ester injection).

Side Effects and Management

Tamoxifen is generally safe, but side effects are possible and include rare but noteworthy visual issues.

• Rare Side Effects: Side effects are rarely seen but may include visual disturbances (e.g., spots or flashes), hot flashes, nausea, and minor hormonal problems (e.g., reduction of insulin). Any vision problem should be reported immediately.

• Long-Term Use: It can be used for long-term treatment (up to 4 months) to fully restore natural testosterone levels safely.

Frequently Asked Questions (FAQs)

1. What is the fundamental difference between Nolvadex (SERM) and Anastrozole (AI)?

Nolvadex (SERM) works by blocking estrogen receptors in specific tissues (like the breast and pituitary). It does not lower the total amount of estrogen in the blood. Anastrozole (AI) works by blocking the aromatase enzyme, thus reducing the actual concentration of estrogen circulating in the blood.

2. Can Nolvadex be used to reverse existing gynecomastia?

Yes. Nolvadex is effective at treating developing gynecomastia and can often reduce the size of the glandular tissue, especially if treatment is started early. However, for established, mature gyno tissue, a stronger SERM like Raloxifene or surgery is often necessary.

3. Should I use Nolvadex or Clomid in my PCT?

Both are effective SERMs and are often used together. Nolvadex is considered more potent for breast tissue blockade (gyno prevention). Clomid is often slightly more potent at stimulating LH/FSH release to restore testosterone. Combining them (e.g., Nolvadex 20 mg daily and Clomid 50 mg daily) provides a robust recovery protocol.

4. Why is Nolvadex usage linked to reduced water retention?

While Nolvadex does not directly lower circulating estrogen (which causes water retention), by blocking estrogen’s action at certain receptor sites, it can provide a cosmetic drying effect. Its primary anti-estrogenic benefit, however, is gyno prevention.